Integral Diagnostics Limited
ASX: IDX
Network expansion and high-value imaging drive Integral Diagnostics’ strong earnings growth.
(Source: TradingView) 3-Month Performance Profile of IDX on a DTF compared to S&P/ASX 200 (XJO).
Integral Diagnostics posted a strong FY25 EBITDA of $113.82 million, representing a 28% year-on-year rise, while operating cash flow increased 11.5% to $73.77 millio
🔒
Subscribers only
Sign in with your subscriber account or subscribe to access this research report.
Required subscription
Daily Digest
A$200.00
Already a subscriber?
Sign in to read this report.
Required subscription
Daily Digest
Stay informed with expert daily ASX research covering four carefully selected stocks, complete with market insights, risk ratings, and clear Buy, Hold, or Sell general guidance—delivered before the market opens each trading day.
- ✓ Four Expert-Selected ASX Stocks Daily
- ✓ Weekday Pre-Market Delivery
- ✓ In-Depth Research & Analysis
- ✓ Access to All Previous Reports
A$200.00/ 12 months
Risk:Medium
Subscribe Now →
